C
Curis
CRIS
4.83000
USD
-0.6
(-11.05%)
مغلق
حجم التداول
542
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
31,150,303
الأخبار
العنوان: Curis
القطاع: Healthcare
الصناعة: Biotechnology
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advancedsolid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.